海外の治験の状況「1」での検索結果
1495件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients
- Diabetes Mellitus Type 2;Hyperglycemia
- Austria
- 2009-03-07
Not recruiting
- FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years
- Encephalitis, Tick-borne
- Austria, Germany
- 2005-09-08
Not Recruiting
- Zur Frage des neuroleptikainduzierten metabolischen Syndroms. Studie 1: Fettverteilung und spezifische hormonelle Parameter. Eine prospektive Vergleichsstudie zwischen 5 atypischen Neuroleptika
- Einschlusskriterien: - Schizophrenie, schizoaffektive Störung oder akut polymorph psychotische Störung - Alter: zwischen 18 und 70 Jahren - Vorliegen einer schriftlichen Einverständniserklärung zur Studienteilnahme Ausschlusskriterien: - Bestehende Kontraindikation gegen eines der atypischen Neuroleptika - MRI Kontraindikationen - BMI über 33
- Austria
- 2006-10-10
Not recruiting
- Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old
- Infections, Meningococcal;Infections, Meningococcal;Infections, Meningococcal
- Austria, Greece
- 2005-09-13
Not recruiting
- A trial of the effect of probiotics on the development of atopy and eczema in children
- Eczema, Atopy
- New Zealand
- 2007-10-09
Recruiting
- A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)
- MPN (Myeloproliferative Neoplasms)
- Austria, Canada, France, Germany, Italy, Spain, Switzerland, United Kingdom, United States
- 2017-01-04
Not Recruiting
- Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study
- Other and unspecified disorders of the circulatory system
- Australia, Austria, Canada, Egypt, Finland, France, Germany, India, Iran (Islamic Republic of), Ireland, Israel, Italy, Jordan, Lebanon, Russian Federation, Spain, Switzerland, Turkey, United Kingdom, United States of America
- 2018-09-07
Recruiting
- Glucagaon-like peptide (GLP-1) and Adipose Tissue Inflammation in Obesity Study
- Obesity
- ,Outside, New Zealand
- 2014-07-28
Authorised
- Efficacy of Endothelin 1 receptor antagonist Bosentan in secondary Raynauds Syndrom - Bosentan1
- secondary Raynauds Syndrome
- Austria
- 2005-01-18
Not recruiting
- A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus
- Diabetes;Diabetes Mellitus, Type 1
- Austria
- 2016-10-17
